SCHEMBL25243192

SCHEMBL25243192

COc1cc(CC(=O)Nc2cccc(-c3cccc(OC(=O)CC4CCCCC4)c3)c2)ccc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.46
LMNA P02545 6/20 0.46
HTT P42858 4/20 0.46
NPSR1 Q6W5P4 4/20 0.46
MAPT P10636 3/20 0.46
TSHR P16473 3/20 0.46
MAPK1 P28482 3/20 0.46
HSD17B10 Q99714 3/20 0.46
ALDH1A1 P00352 2/20 0.46
STAT3 P40763 2/20 0.46
TP53 P04637 2/20 0.46
HPGD P15428 1/20 0.46
XBP1 P17861 1/20 0.46
HTR1E P28566 1/20 0.46
NTSR1 P30989 1/20 0.46
STAT1 P42224 1/20 0.46
S1PR3 Q99500 1/20 0.46
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
ROCK2 O75116 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26379418 0.92 SMN1; SMN2 (0.47) SMN1; SMN2LMNAHTTNPSR1MAPT
SCHEMBL30595569 0.92 SMN1; SMN2 (0.47) SMN1; SMN2LMNAHTTNPSR1MAPT
SCHEMBL26072048 0.90 KDM4C (0.44) SMN1; SMN2LMNAHTTNPSR1MAPT
SCHEMBL25286311 0.86 LMNA (0.45) SMN1; SMN2LMNAHTTNPSR1MAPT
SCHEMBL25284067 0.85 SMN1; SMN2 (0.53) SMN1; SMN2LMNAHTTNPSR1MAPT
SCHEMBL25293379 0.84 USP2 (0.56) SMN1; SMN2LMNAHTTNPSR1MAPT
SCHEMBL30486752 0.83 SMN1; SMN2 (0.55) SMN1; SMN2LMNAHTTNPSR1MAPT
SCHEMBL26379378 0.83 SMN1; SMN2 (0.55) SMN1; SMN2LMNAHTTNPSR1MAPT
SCHEMBL26072164 0.81 AURKA (0.46) SMN1; SMN2TP53KMT2AMEN1ROCK2
SCHEMBL25242365 0.81 SMN1; SMN2 (0.53) SMN1; SMN2LMNAHTTNPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12590063-B2 Phenol derivative Sumitomo Pharma Co., Ltd. (JP) 2026-03-31 US disclosed
US-20230312474-A1 PHENOL DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2023-10-05 US disclosed
US-20230312474-A1 PHENOL DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2023-10-05 US disclosed
EP-4206184-A1 PHENOL DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2023-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12590063-B2 Phenol derivative HDAC3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HNF4A SMN1; SMN2 2226/4885LMNA 1741/4885HTT 2192/4885
US-20230312474-A1 PHENOL DERIVATIVE TYR, NCOR1, BET1 SMN1; SMN2 2949/4885LMNA 1203/4885HTT 3055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.